{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Inhaled+placebo+%2B+oral+placebo", "query": { "intervention": "Inhaled placebo + oral placebo" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 179, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Inhaled+placebo+%2B+oral+placebo&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-04T06:43:18.758Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02948959", "title": "Evaluation of Dupilumab in Children With Uncontrolled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Asthma Controller Therapies", "type": "DRUG" }, { "name": "Asthma Reliever Therapies", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 408, "start_date": "2017-04-21", "completion_date": "2020-08-26", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Gilbert, Arizona • Tucson, Arizona + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Owensboro", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT02948959" }, { "nct_id": "NCT02054156", "title": "OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "azithromycin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "Tobramycin solution for inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bonnie Ramsey", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Months to 18 Years" }, "enrollment_count": 221, "start_date": "2014-06", "completion_date": "2018-08-23", "has_results": true, "last_update_posted_date": "2019-10-01", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 45, "location_summary": "Anchorage, Alaska • Tucson, Arizona • Little Rock, Arkansas + 40 more", "locations": [ { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02054156" }, { "nct_id": "NCT07179380", "title": "Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Hypertension", "Interstitial Lung Disease" ], "interventions": [ { "name": "Treprostinil Palmitil Inhalation Powder", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 344, "start_date": "2026-01-07", "completion_date": "2028-12-30", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Fresno, California • Los Angeles, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07179380" }, { "nct_id": "NCT07661446", "title": "Cannabis and Opioid Use Disorder, Study 2", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Opioid Use Disorders", "Cannabis Use" ], "interventions": [ { "name": "Inhaled Cannabis", "type": "DRUG" }, { "name": "Intranasal Opioid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Kentucky", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 100, "start_date": "2026-10-01", "completion_date": "2030-01-30", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT07661446" }, { "nct_id": "NCT03444298", "title": "A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Airway Inflammation", "Asthma" ], "interventions": [ { "name": "Gamma Tocopherol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 16, "start_date": "2018-06-08", "completion_date": "2023-03-06", "has_results": true, "last_update_posted_date": "2024-02-05", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03444298" }, { "nct_id": "NCT02141854", "title": "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol/salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 882, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 85, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02141854" }, { "nct_id": "NCT00910689", "title": "Drug and Non-Drug Treatment Of Severe Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine Headache" ], "interventions": [ { "name": "Propranolol or nadolol", "type": "DRUG" }, { "name": "Placebo control", "type": "DRUG" }, { "name": "Behavioral Migraine Management (BMM)", "type": "BEHAVIORAL" }, { "name": "Optimal Acute Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Ohio University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 232, "start_date": "2001-07", "completion_date": "2005-11", "has_results": true, "last_update_posted_date": "2016-11-22", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 2, "location_summary": "Athens, Ohio • Westerville, Ohio", "locations": [ { "city": "Athens", "state": "Ohio" }, { "city": "Westerville", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00910689" }, { "nct_id": "NCT03118765", "title": "Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "GSP304 (tiotropium bromide) Inhalation Solution", "type": "DRUG" }, { "name": "GSP304 Placebo Inhalation Solution", "type": "DRUG" }, { "name": "Spiriva® Respimat® inhalation spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Specialty S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 155, "start_date": "2017-03-24", "completion_date": "2017-07-31", "has_results": true, "last_update_posted_date": "2019-08-01", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 25, "location_summary": "Andalusia, Alabama • Phoenix, Arizona • Tempe, Arizona + 18 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Edgewater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03118765" }, { "nct_id": "NCT07481981", "title": "A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Arterial Hypertension" ], "interventions": [ { "name": "Treprostinil Palmitil Inhalation Powder", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 344, "start_date": "2026-07-21", "completion_date": "2029-01-28", "has_results": false, "last_update_posted_date": "2026-09-16", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 8, "location_summary": "Los Angeles, California • Santa Barbara, California • Torrance, California + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Kansas City", "state": "Kansas" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT07481981" }, { "nct_id": "NCT00543062", "title": "Staccato Prochlorperazine Thorough QT/QTc", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiotoxicity" ], "interventions": [ { "name": "Inhaled placebo", "type": "DRUG" }, { "name": "Oral placebo", "type": "DRUG" }, { "name": "Inhaled prochlorperazine 5 mg", "type": "DRUG" }, { "name": "Inhaled prochlorperazine 10 mg", "type": "DRUG" }, { "name": "Oral moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexza Pharmaceuticals, Inc.", "sponsor_class": "UNKNOWN", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2007-10", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2019-03-11", "last_synced_at": "2026-10-04T06:43:18.758Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00543062" } ] }